Applied Genetic Technologies Corporation announced the appointment of Theresa G.H. Heah, M.D., M.B.A. to the position of Chief Medical Officer. Dr. Heah will replace Matthew Feinsod, M.D., who will transition to a new role with responsibilities for developing and implementing global clinical and regulatory strategy, due diligence and licensing. AGTC also announced the appointment of Brian Krex as General Counsel, who will oversee the company’s legal function. Dr. Heah brings more than ten years of senior executive pharmaceutical experience to her new role, with previous responsibilities ranging from drug development to successful product commercialization. Most recently, Dr. Heah was Vice-President of Clinical Research, Medical, and Professional Affairs at Aerie Pharmaceuticals and had responsibility as global head for clinical research, medical affairs and professional affairs, and advancing the company’s pipeline of product candidates to approval and launch. Prior to joining AGTC, Brian Krex was Vice President and Global Head of Commercial and Regulatory Law with Alexion Pharmaceuticals, and also served as their Interim Chief Compliance Officer.